The Motley Fool

Forget the Centrica share price! I’d invest in these UK shares instead

Image source: Getty Images.

The Centrica (LSE: CNA) share price has been engaged in a relentless down-trend for around seven years. Since the autumn of 2013, the stock has fallen by around 90%, crashing out of the FTSE 100 this year on the way down.

You don’t need me to tell you it’s been a terrible investment for its shareholders. And I wouldn’t rush in to buy the shares now for their recovery potential. Indeed, the company has been suffering from poor trading for a long while.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Why the Centrica share price has been falling

Customers have been abandoning the company’s energy supply arm, British Gas. And the firm’s upstream operations have suffered from weaker oil prices. Of course, the arrival of the Covid-19 pandemic hasn’t helped matters, but Centric is trying hard to turn its business around.

Part of the strategy involves simplifying operations with asset sales. And the recently announced agreement to sell the North American energy supply, services and trading business, Direct Energy, will help. The deal is worth around £2.85bn and will go some way to reduce Centrica’s gargantuan debt on its balance sheet.

However, less encouraging is the news that the divestment process for the its Nuclear assets has been “paused”. And the firm’s Spirit Energy E&P divestment process will restart “once commodity and financial markets have settled.” I can’t help thinking we’ll be in for a long wait for that one.

Generally, I’m not a big fan of investing in businesses that have been under-performing for years in the hope they can turn themselves around. And I’m even less enthused by the idea when a company carries a big weight of debt like Centrica does. The company may succeed, but it operates in a difficult and cyclical sector.

Here’s where I’d invest right now

Instead, I’d rather look for enduring FTSE investments in stronger sectors. For example, medical devices company Smith & Nephew looks set to recover well from the coronavirus setback. City analysts have pencilled in a more than 50% resurge in earnings for 2021, which should move profits higher than before the crisis. Meanwhile, the share price continues to languish well down from its highs.

In the fast-moving consumer goods sector, there are a couple of interesting recovery plays I’d go for instead of Centrica. One is the FTSE 250’s PZ Cussons, which has been rising on turnaround hopes after experienced FMCG chief executive Jonathon Myers took the helm in May.  And I like the look of Premier Foods, which is experiencing resurgent profits following a programme to re-vitalise its brands. The company is further along the recovery trail than PZ Cussons but still looks like a decent investment to me.

There are many other shares I’d rather buy than Centrica too. But in the current environment with coronavirus and general economic weakness, I’d also be interested in buying tracker funds. Sometimes broad-brush investing can be a good option, particularly if you hold your investments for decades. For example, I’d be keen to find trackers that follow the FTSE 100 index, the FTSE 250 and America’s S&P 500 to begin with.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Kevin Godbold owns shares in PZ Cussons. The Motley Fool UK has recommended PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.